← Back to Search

Omega-3 Supplement

Omega-3 (EPA+DHA) for COVID-19

Phase 1
Waitlist Available
Led By Arunima Sarkar, MD
Research Sponsored by Hackensack Meridian Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Must be experiencing 1+ ongoing covid-19 symptom being measured in this study (respiratory symptoms (shortness of breath, cough), fatigue, loss of taste, loss of smell)
Symptom(s) coincided with covid-19 infection and were not present prior to covid-19 infection
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months recruitment efforts (starting on actual study start date)
Awards & highlights

Study Summary

This trial is testing whether omega-3 supplements can help with after-effects of coronavirus-19.

Eligible Conditions
  • COVID-19
  • Coronavirus

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You currently have at least one of the following symptoms: cough, shortness of breath, fatigue, loss of taste or loss of smell.
Select...
You have symptoms that started when you got COVID-19 and you didn't have them before.
Select...
You are not allergic to soy.
Select...
You are not allergic to fish.
Select...
You are not taking high-dose supplements such as omega-3, zinc, vitamin C, or elderberry that may help with the recovery of long COVID syndrome.
Select...
You can take six small pills every day without difficulty.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months recruitment efforts (starting on actual study start date)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months recruitment efforts (starting on actual study start date) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility study for omega-3 fatty acid supplementation v. placebo in adult patients to limit long covid syndrome - Compliance as captured by the number of participants who remain compliant for the whole duration of the study by taking all pills daily
Feasibility study for omega-3 fatty acid supplementation v. placebo in adult patients to limit long covid syndrome - Recruitment as illustrated by the number of screen failures (potential participants approached but not interested in participating).
Feasibility study for omega-3 fatty acid supplementation v. placebo in adult patients to limit long covid syndrome - Retention as illustrated by the number of participants that initiate but do not complete the study.
Secondary outcome measures
Impact of omega-3 supplement on post-covid symptoms - Cough
Impact of omega-3 supplement on post-covid symptoms - Fatigue
Impact of omega-3 supplement on post-covid symptoms - Loss of smell
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Study arm - Omega 3 supplementExperimental Treatment1 Intervention
Omega-3 (EPA+DHA) - Dose is 2,100mg per day via 3 mini-capsules, 2x/day (a total of 6 mini-capsules per day). Each capsule has 252mg of EPA and 102mg of DHA.
Group II: Control arm - placeboPlacebo Group1 Intervention
3 Soybean Oil Placebo capsules 2x/day (a total of 6 mini-capsules per day).

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Hackensack Meridian HealthLead Sponsor
131 Previous Clinical Trials
28,212 Total Patients Enrolled
7 Trials studying COVID-19
4,632 Patients Enrolled for COVID-19
Arunima Sarkar, MDPrincipal InvestigatorHackensack Meridian Health

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any other precedents for clinical trials on the Omega-3 fatty acids (EPA+DHA) combination?

"Presently, there are 17 studies underway into the efficacy and safety of Omega-3 (EPA+DHA), 4 of which have reached Phase 3. A multitude of medical centres across 34 cities in America are involved in these trials; many based out of Boston, Massachusetts."

Answered by AI

What objectives is this research endeavor attempting to achieve?

"The primary goal of this clinical trial over the course of 12 weeks is to measure compliance among participants by tracking those who stay committed to taking their omega-3 supplements. Secondary endpoints include self reported levels of shortness of breath, coughing, and smell loss before and after said treatment period."

Answered by AI

Is this a pioneering medical trial?

"Omega-3 (EPA+DHA) has been an active area of research since 2005, when Abbott sponsored the first study involving 15480 patients. After receiving Phase 4 drug approval in light of that early trial, there have now been 17 investigations conducted across 11 nations and 7 cities."

Answered by AI

What eligibility criteria must potential participants fulfill to join this research?

"This clinical study is looking for 100 volunteers with Covid-19 between 18 and 89 years old. To qualify, they must be affiliated with Hackensack Meridian Health, have experienced symptoms that began after their initial infection of the virus, not possess a soy or fish allergy and should have had those same lingering symptoms for over 3 months."

Answered by AI

Does this research accept participants aged thirty and over?

"In order to be eligible for this trial, patients must have attained the age of consent and not surpassed 89 years old. Interestingly, there are 141 clinical trials exclusively targeting those under 18 and 912 studies specifically catered towards individuals over 65."

Answered by AI

What is the enrollment figure for this experiment?

"Verified. According to information hosted on clinicaltrials.gov, this medical trial is currently seeking volunteers who meet the eligibility criteria. The initial posting was made January 10th 2022 with a subsequent edit occurring April 12th 2022; 100 people are needed from 1 site for participation in the study."

Answered by AI

Has the FDA given its blessing to Omega-3 (EPA+DHA) supplements?

"As this is a Phase 1 trial, with limited evidence to back its safety and efficacy, Omega-3 (EPA+DHA) scored a 1 on our team's scale."

Answered by AI

Is this research project still recruiting participants?

"Affirmative. According to clinicaltrials.gov, this research endeavour is currently seeking participants and was first posted on the 10th of January 2022; its most recent update was conducted April 12th 2022. Specifically, it requires 100 test subjects from a single medical centre."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Feasibility Pilot Clinical Trial of Omega-3 Supplement vs. Placebo for Post Covid-19 Recovery Among Health Care Workers
2022. "Feasibility Pilot Clinical Trial of Omega-3 Supplement vs. Placebo for Post Covid-19 Recovery Among Health Care Workers". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05121766.
~10 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top